
Dr. Bret Scher and psychiatrist Dr. Lori Calabrese discuss the complexities of ketogenic therapy in mental health treatment, focusing on a case of a young woman with schizophrenia and rising LDL cholesterol levels.
We’re seeing increasingly compelling results from ketogenic therapy in serious mental illness, including schizophrenia, bipolar disorder, and major depression. But what happens when a potential concern emerges along the way? In this conversation, Dr. Bret Scher sits down with psychiatrist Dr. Lori Calabrese to walk through a real patient case that highlights both the promise and the complexity of metabolic treatment. A young woman with longstanding schizophrenia experienced dramatic improvements in her mental health, metabolic markers, and quality of life after starting a ketogenic intervention. But alongside these gains, her LDL cholesterol rose significantly, raising important clinical questions. Rather than defaulting to extremes, either stopping the therapy or ignoring the lab values, Dr. Calabrese takes a thoughtful, patient-centered approach: Investigating deeper cardiovascular risk markers Exploring potential underlying causes, including familial hypercholesterolemia Collaborating across specialties, including cardiology Prioritizing both psychiatric recovery and long-term health This case illustrates a critical principle in metabolic psychiatry: context matters. Lab…
Host: Bret Scher
Guest: Lori Calabrese
Organizations: Metabolic Mind, cardiology
Explore listener stats, chart rankings, contacts and more on the Metabolic Mind podcast page.